The regulation of SIRT3-related signaling in cancer processes implicate that SIRT3 might be a potential therapeutic target in cancer management [7, 28], but the obvious Janus-faced role of SIRT3 suggests that different treatment strategies should be employed in various cancer developmental stages in order to achieve better therapeutic efficacy. Here, SIRT3 is linked to cancer.